Showing results (871-880 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|April 20, 2018
Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in CanadaDarrien D Rattray, Laura Weins, Lexy C Regush, et al.Clinicoeconomics and Outcomes Research : CEOR|June 9, 2018
Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis managementErkki Soini, Ossi Riekkinen, Heikki Kröger, et al.Clinicoeconomics and Outcomes Research : CEOR|June 13, 2018
Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost-consequence modelAlistair S Curry, Shkun Chadda, Aurélie Danel, et al.Clinicoeconomics and Outcomes Research : CEOR|June 14, 2019
Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the USMurtuza Bharmal, Mairead Kearney, Ying Zheng, et al.Clinicoeconomics and Outcomes Research : CEOR|June 29, 2018
Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in MacedoniaVjollca Qerimi, Aleksandra Kapedanovska Nestorovska, Zoran Sterjev, et al.Clinicoeconomics and Outcomes Research : CEOR|January 25, 2021
Burden of Male Hypogonadism and Major Comorbidities, and the Clinical, Economic, and Humanistic Benefits of Testosterone Therapy: A Narrative ReviewSandy Yeo, Katsiaryna Holl, Nicolás Peñaherrera, et al.Clinicoeconomics and Outcomes Research : CEOR|October 1, 2019
Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisonsGabriel Tremblay, Tracy Westley, Joseph C Cappelleri, et al.Clinicoeconomics and Outcomes Research : CEOR|August 27, 2019
Characteristics and outcome of high-cost ICU patientsYin Nwe Aung, Amrizal M Nur, Aniza Ismail, et al.Clinicoeconomics and Outcomes Research : CEOR|February 26, 2019
Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective studyBerna Demiralp, Lane Koenig, Jaya Kala, et al.Clinicoeconomics and Outcomes Research : CEOR|May 10, 2012
Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD modelTamlyn Anne Rautenberg, Ute Zerwes, Douglas Foerster, et al.Pageof 102